Table 2.
Clinical Characteristics of Participants with LCVA
Participant | Months Post CVA |
Brodmann’s areas lesioned* | Total voxels lesioned |
---|---|---|---|
Patient TO | 105 | 21,22,37,39,40,41,42,43,44 | 39,674 |
OM | 74 | 1,2,3,7,19,21,22,37,39,40,41,42,43 | 32,238 |
MA | 69 | 6,44,47 | 2,288 |
AG | 129 | 6,9,45,46 | 72,991 |
GH | 75 | 7,22,39,40,41,42 | 57,196 |
LL | 101 | 1,2,3,4,9,22,32,34,38,39,40,41,42,43,45,47 | 27,492 |
Avg. (sd) | 92 (24) | 38,646 (24,544) |
≥10% damage to listed regions